Clinical Trial Update: Use of an Oral Beta-2 Agonist in Persons With Spinal Cord Injury [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reporting results from Phase 2 and Phase 3 studies evaluating an oral beta-2 agonist in persons with spinal cord injury; status completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Spinal Cord Injury | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2014-07-16